# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053964
Filing Date
2024-05-07
Accepted
2024-05-07 08:05:35
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | hrtx-20240331.htm iXBRL | 10-Q | 1169991
2 | EX-10.1 | hrtx-ex10_1.htm | EX-10.1 | 206048
3 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 15131
4 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 14938
5 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 16456
| Complete submission text file | 0000950170-24-053964.txt |  | 6330307

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20240331.xsd | EX-101.SCH | 909126
64 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20240331_htm.xml | XML | 1129816

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 24919713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)